16 November 2026
Latham & Watkins Advises on Vir Biotechnology’s US$150 Million Public Offering of Common Stock
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Drew Capurro Lead | Latham & Watkins LLP | Partner | corporate | Orange County |
| Greg Van Buiten | Latham & Watkins LLP | Associate | corporate | Not stated |
| Caitlin Nguyen | Latham & Watkins LLP | Associate | corporate | Not stated |
| Brock Meyer | Latham & Watkins LLP | Associate | corporate | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | regulatory | Bay Area |
| Betty Pang | Latham & Watkins LLP | Partner | regulatory | Bay Area |
| Chad Jennings | Latham & Watkins LLP | Counsel | regulatory | Washington, D.C. |
| Kris Kenn | Latham & Watkins LLP | Associate | regulatory | Not stated |
| Rob Yeh | Latham & Watkins LLP | Counsel | intellectual property | San Diego |
| Andrew Wang | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Francis Shih | Latham & Watkins LLP | Not stated | tax | Not stated |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 150m (US$150 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Vir Biotechnology, Inc. (Issuer)